The first needle-free dosage form of epinephrine was approved by FDA in August 2024. neffy (epinephrine nasal spray–ARS Pharmaceuticals) is a pocket-sized nasal spray approved for emergency treatment of type 1 allergic reactions, including anaphylaxis, in adult and pediatric patients who weigh 30 kg (66 lbs) or greater.

Lauren Howell, PharmD

Bronchitis and upper respiratory tract infections often come with a side of acute cough. A wide range of antitussive agents and expectorants to treat symptomatic cough are available over the counter.

Mickie Cathers

Wounds are defined as any injury that causes a break in the skin, including abrasions (from rubbing or friction) and lacerations (from a sharp-edged object).

Mary Warner

Updates from FDA

Results from a June 21, 2024, NEJM study suggest that tirzepatide may be a potential treatment for the more than 900 million people worldwide affected by sleep apnea.

Lauren Howell, PharmD